| GO | Name |
| GO:0001822 | kidney development |
| GO:0004957 | prostaglandin E receptor activity |
| GO:0005615 | extracellular space |
| GO:0005654 | nucleoplasm |
| GO:0005737 | cytoplasm |
| GO:0005829 | cytosol |
| GO:0006693 | prostaglandin metabolic process |
| GO:0007179 | transforming growth factor beta receptor signaling pathway |
| GO:0007565 | female pregnancy |
| GO:0007567 | parturition |
| GO:0016323 | basolateral plasma membrane |
| GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity |
| GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0030728 | ovulation |
| GO:0032355 | response to estradiol |
| GO:0032496 | response to lipopolysaccharide |
| GO:0042802 | identical protein binding |
| GO:0043065 | positive regulation of apoptotic process |
| GO:0045471 | response to ethanol |
| GO:0045786 | negative regulation of cell cycle |
| GO:0051287 | NAD binding |
| GO:0070403 | NAD+ binding |
| GO:0070493 | thrombin-activated receptor signaling pathway |
| GO:0097070 | ductus arteriosus closure |
| GO:1904707 | positive regulation of vascular associated smooth muscle cell proliferation |
| GO:1905828 | regulation of prostaglandin catabolic process |